Search Results for: liver embolization

Chemoembolization and Bland Embolization of Neuroendocrine Tumor Metastases to the Liver (Full text)

July 1, 2007

Conclusions: Chemoembolization was not associated with a higher degree of toxicity than bland embolization. Chemoembolization demonstrated trends toward improvement in TTP, symptom control, and survival. Based on these results, a multicenter…

READ MORE

The Role of Surgery and Chemoembolization in the Management of Carcinoid

November 1, 2015

Presented by:
Rodney Pommier, MD, FACS
Associate Professor of Surgery, Division of General Surgery,
Section of Surgical Oncology
Oregon Health Sciences University
California Carcinoid Fighters Conference
October 25, 2003

It’s a real pleasure…

READ MORE

Liver-Directed Therapies in Patients With Advanced Neuroendocrine Tumors

October 24, 2015

Natalie B. Jones, MD; Manisha H. Shah, MD; Mark Bloomston, MD
CME Released: 06/04/2012; Valid for credit through 06/04/2013, From JNCCN — Journal of the National Comprehensive Cancer Network

This activity is intended for primary care physicians,…

READ MORE

Hepatic artery embolization (bland embolization)

October 17, 2015

Hepatic artery embolization: Another option for tumors that cannot be removed is to reduce the blood flow through the hepatic artery, the artery that feeds most liver cancer cells. This is done by hepatic artery embolization (injecting materials that…

READ MORE

Hepatic artery chemoembolization (HACE) (also called TACE)

October 17, 2015

HACE is the localized treatment of a tumor that spars healthy tissue and organ function. Chemoembolization is used to treat tumors in the liver. The normal liver has a dual blood supply with the hepatic artery supplying 25% and the portal vein supplying…

READ MORE

Chemoembolization

October 17, 2015

A procedure in which the blood supply to the tumor is blocked surgically or mechanically and anticancer drugs are administered directly into the tumor. This permits a higher concentration of drug to be in contact with the tumor for a longer period of time.…

READ MORE

In your editorial section on treatment, liver transplant “in very special selected cases” is mentioned; what are those cases?

October 17, 2015

The reported world experience with liver transplant for carcinoid indicates that the outcome in general is as good but no better than that resulting from the best combination of multimodality treatment ( i.e. Octreotide/Sandostatin, Hepatic Artery…

READ MORE

Treatment of liver metastases in patients with neuroendocrine tumors: a comprehensive review.

October 13, 2011

Patients diagnosed with Neuroendocrine Tumors (NET) often are also diagnosed with Neuroendocrine Liver Metastases (NLM) during the course of their disease. NLM can cause significant morbidity and mortality, oftentimes much more than compared to…

READ MORE

Prolonged survival after hepatic artery embolization in patients with midgut carcinoid syndrome

May 1, 2009

Conclusion: Hepatic Arery Embolization is safe, provides good control of hormonal symptoms, and prolongs survival in biochemically responsive patients. It is a valuable palliative option for patients with midgut carcinoid syndrome due to liver …

READ MORE

Consensus Statements and Guidelines

October 29, 2015

This section provides information on consensus findings from leading international and national researchers and physicians in the field of carcinoid and neuroendocrine tumors.

The North American Neuroendocrine Tumor Society (NANETS) GuidelinesREAD MORE